中华医学杂志(英文版)
中華醫學雜誌(英文版)
중화의학잡지(영문판)
CHINESE MEDICAL JOURNAL
2001年
10期
1084-1088
,共5页
黄致治%申延琴%梁英锐%吴贤英
黃緻治%申延琴%樑英銳%吳賢英
황치치%신연금%량영예%오현영
食管肿瘤基底细胞样鳞状细胞癌免疫组织化学
食管腫瘤基底細胞樣鱗狀細胞癌免疫組織化學
식관종류기저세포양린상세포암면역조직화학
目的了解食管基底细胞样鳞状细胞癌(BSC)的生物学特点。
方法食管基底细胞样鳞状细胞癌8例,用CK4,CK18,CK19,EMA,CEA,α-SMA,S-100,LN,Col-Ⅳ,
NSE,PCNA,p53等12种抗体进行免疫组化常规ABC法检测。
结果 BSC的两种细胞成分,即基底样细胞(BC)和鳞状细胞(SC)对上述抗体反应截然不同。绝大部分病
例(7例)BC专一地对CK19抗体呈阳性反应,而对其它4种上皮性抗体呈阴性反应;有4例BC对α-SMA
及S-100肌性抗体呈阳性;BC巢内玻璃样物对LN及Col-Ⅳ呈阳性反应;BC有较高的PCNA指数,平均为
54%。相反,7例SC成分均对CK4、CEA、EMA等上皮性抗体呈阳性;对CK19、α-SMA、S-100呈阴性;
PCNA指数较低,平均为25%。
结论食管BSC为多向分化的高度恶性肿瘤。BC代表向基底细胞和肌上皮方向分化,其增殖活性强;而
SC代表向典型的鳞状细胞分化。
目的瞭解食管基底細胞樣鱗狀細胞癌(BSC)的生物學特點。
方法食管基底細胞樣鱗狀細胞癌8例,用CK4,CK18,CK19,EMA,CEA,α-SMA,S-100,LN,Col-Ⅳ,
NSE,PCNA,p53等12種抗體進行免疫組化常規ABC法檢測。
結果 BSC的兩種細胞成分,即基底樣細胞(BC)和鱗狀細胞(SC)對上述抗體反應截然不同。絕大部分病
例(7例)BC專一地對CK19抗體呈暘性反應,而對其它4種上皮性抗體呈陰性反應;有4例BC對α-SMA
及S-100肌性抗體呈暘性;BC巢內玻璃樣物對LN及Col-Ⅳ呈暘性反應;BC有較高的PCNA指數,平均為
54%。相反,7例SC成分均對CK4、CEA、EMA等上皮性抗體呈暘性;對CK19、α-SMA、S-100呈陰性;
PCNA指數較低,平均為25%。
結論食管BSC為多嚮分化的高度噁性腫瘤。BC代錶嚮基底細胞和肌上皮方嚮分化,其增殖活性彊;而
SC代錶嚮典型的鱗狀細胞分化。
목적료해식관기저세포양린상세포암(BSC)적생물학특점。
방법식관기저세포양린상세포암8례,용CK4,CK18,CK19,EMA,CEA,α-SMA,S-100,LN,Col-Ⅳ,
NSE,PCNA,p53등12충항체진행면역조화상규ABC법검측。
결과 BSC적량충세포성분,즉기저양세포(BC)화린상세포(SC)대상술항체반응절연불동。절대부분병
례(7례)BC전일지대CK19항체정양성반응,이대기타4충상피성항체정음성반응;유4례BC대α-SMA
급S-100기성항체정양성;BC소내파리양물대LN급Col-Ⅳ정양성반응;BC유교고적PCNA지수,평균위
54%。상반,7례SC성분균대CK4、CEA、EMA등상피성항체정양성;대CK19、α-SMA、S-100정음성;
PCNA지수교저,평균위25%。
결론식관BSC위다향분화적고도악성종류。BC대표향기저세포화기상피방향분화,기증식활성강;이
SC대표향전형적린상세포분화。
Objective To explore the biological features of basaloid squamous cell carcinoma (BSC) of the
esophagus.
Methods Cytokeratins (CK4, CK18 and CK19), epithelial membrane antigen (EMA), carcino embryo
antigen (CEA), α-smooth muscle antigen (α-SMA), S-100, laminin (LN), collagen Ⅳ (Col-Ⅳ), neural
specific enolase (NSE), proliferating cell nuclear antigen (PCNA) and p53 antibodies were used to detect
the corresponding antigen expression in 8 cases of BSC with ABC immunohistochemical methods.
Results Two kinds of BSC cell components have different responses to the above antibodies. For
basaloid cells (BCs), 7 cases were positive for CK19, and were negative for the other 4 epithelial
antibodies CK4, CK18, CEA and EMA. BCs of 4 cases were positive to the muscular antibodies α-SMA
and S-100, and the hyaline degeneration in the tumor nests was positive for LN and Col-Ⅳ. BCs had a
high index of PCNA, with an average level of 54%. For squamous cells (SCs), 7 cases were positive for
the epithelial antigen CK4, CEA and EMA, but were negative for CK19, α-SMA and S-100. The index of
PCNA of SC was low, with an average level of 25%.
Conclusion BSC of the esophagus is a high-malignancy tumor which is of multi-oriented differentiation.
BCs represent basal cells which have the tendency of myoepithelial differentiation and have strong
proliferation ability, whereas SCs represent typical squamous cell differentiation.